2011
Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania
Kawai K, Villamor E, Mugusi FM, Saathoff E, Urassa W, Bosch RJ, Spiegelman D, Fawzi WW. Predictors of change in nutritional and hemoglobin status among adults treated for tuberculosis in Tanzania. The International Journal Of Tuberculosis And Lung Disease 2011, 15: 1380-1389. PMID: 22283899, PMCID: PMC3404808, DOI: 10.5588/ijtld.10.0784.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnemiaAntitubercular AgentsBiomarkersBody Mass IndexCoinfectionFemaleHealth Status IndicatorsHemoglobinsHIV InfectionsHumansLinear ModelsMaleMalnutritionMultivariate AnalysisNutritional StatusNutritional SupportProspective StudiesTanzaniaTime FactorsTreatment OutcomeTuberculosis, PulmonaryYoung AdultConceptsLow CD4 cell countsHuman immunodeficiency virusBody mass indexCD4 cell countHIV-positive patientsTB treatmentCell countPredictors of changeTB patientsHemoglobin statusHIV-negative TB patientsHIV-positive TB patientsOlder ageHIV-negative adultsHIV-negative patientsPrevious TB infectionHIV-negative participantsAdequate nutritional supportHigh viral loadProfound malnutritionTB infectionPulmonary tuberculosisNutritional recoveryNutritional supportHemoglobin levels
2004
Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy
Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA. Understanding the Role of HIV Load in Determining Weight Change in the Era of Highly Active Antiretroviral Therapy. Clinical Infectious Diseases 2004, 40: 167-173. PMID: 15614708, DOI: 10.1086/426591.Peer-Reviewed Original ResearchConceptsActive antiretroviral therapyVirus loadBody weightAntiretroviral therapyHIV infectionWeight changeStudy visitHuman immunodeficiency virus RNA loadHighly Active Antiretroviral TherapyAbsence of HAARTProspective cohort studyCell count decreaseVirus RNA loadTime of enrollmentStudy intervalRepeated-measures analysisHIV loadHAART useCohort studyRNA loadHAARTPatientsEligible sampleCell countCount decreaseSelenium Status Is Associated with Accelerated HIV Disease Progression among HIV-1–Infected Pregnant Women in Tanzania
Kupka R, Msamanga GI, Spiegelman D, Morris S, Mugusi F, Hunter DJ, Fawzi WW. Selenium Status Is Associated with Accelerated HIV Disease Progression among HIV-1–Infected Pregnant Women in Tanzania. Journal Of Nutrition 2004, 134: 2556-2560. PMID: 15465747, DOI: 10.1093/jn/134.10.2556.Peer-Reviewed Original ResearchConceptsPlasma selenium levelsCD4 cell countRisk of mortalityDisease progressionHIV-1-infected pregnant womenCell countSelenium levelsLow plasma selenium levelsHIV disease progressionAccelerated disease progressionCox multivariate modelSelenium statusMedian followHIV diseaseClinical outcomesPregnant womenPoor survivalTanzanian womenMultivariate modelL increaseCells/ProgressionWomenMortalityFirst yearA Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality
Fawzi WW, Msamanga GI, Spiegelman D, Wei R, Kapiga S, Villamor E, Mwakagile D, Mugusi F, Hertzmark E, Essex M, Hunter DJ. A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality. New England Journal Of Medicine 2004, 351: 23-32. PMID: 15229304, DOI: 10.1056/nejmoa040541.Peer-Reviewed Original ResearchConceptsVitamin AHIV diseaseMultivitamin supplementsHuman immunodeficiency virus (HIV) diseasePlacebo-controlled trialHIV disease progressionStage 4 diseaseLow viral loadHigher CD4Antiretroviral therapyPrimary outcomeImmunodeficiency syndromeRandomized trialsViral loadPregnant womenDisease progressionRelative riskObservational studyDaily supplementCell countEnd pointMicronutrient statusMultivitaminsDiseaseProgressionBreastfeeding and maternal HIV-1 disease progression and mortality
Sedgh G, Spiegelman D, Larsen U, Msamanga G, Fawzi WW. Breastfeeding and maternal HIV-1 disease progression and mortality. AIDS 2004, 18: 1043-1049. PMID: 15096808, DOI: 10.1097/00002030-200404300-00013.Peer-Reviewed Original ResearchConceptsHIV-1 disease progressionCD4 cell countDisease progressionCell countHigher CD4 cell countsLow CD4 cell countsCox proportional hazards modelHealth of HIVCohort study designExcessive weight lossProportional hazards modelPartial breastfeedingRelative riskHazards modelInsufficient evidenceBreastfeedingMultivariate analysisStudy designWeight lossWomenProgressionDar es SalaamHIVDeathAssociation
2003
Role of Acquired Immune Deficiency Syndrome—Defining Conditions in Human Immunodeficiency Virus—Associated Wasting
Wanke CA, Silva M, Ganda A, Fauntleroy J, Spiegelman D, Knox TA, Gorbach SL. Role of Acquired Immune Deficiency Syndrome—Defining Conditions in Human Immunodeficiency Virus—Associated Wasting. Clinical Infectious Diseases 2003, 37: s81-s84. PMID: 12942378, DOI: 10.1086/375894.Peer-Reviewed Original ResearchConceptsRelative riskStudy visitImmune deficiency syndrome-defining conditionsAcquired Immune Deficiency SyndromeMonthly study visitsCD4 cell countHIV Cohort StudyHuman immunodeficiency virusImmune deficiency syndromeBaseline BMICohort studyImmunodeficiency virusDeficiency syndromeCell countEnergy intakeSocioeconomic statusWastingBMIRiskVisitsLongitudinal dataSyndromeIntakeBaselineMonthsEffect of Providing Vitamin Supplements to Human Immunodeficiency Virus-Infected, Lactating Mothers on the Child's Morbidity and CD4+ Cell Counts
Fawzi WW, Msamanga GI, Wei R, Spiegelman D, Antelman G, Villamor E, Manji K, Hunter D. Effect of Providing Vitamin Supplements to Human Immunodeficiency Virus-Infected, Lactating Mothers on the Child's Morbidity and CD4+ Cell Counts. Clinical Infectious Diseases 2003, 36: 1053-1062. PMID: 12684919, DOI: 10.1086/374223.Peer-Reviewed Original ResearchConceptsMultivitamin armCell countVitamin AHuman immunodeficiency virus type 1Immunodeficiency virus type 1Placebo-controlled trialCells/microLHIV-negative childrenHIV-positive childrenHuman immunodeficiency virusChildren of womenRapid respiratory rateVirus type 1Low-cost interventionEffect of supplementationMaternal receiptMean CD4Immunodeficiency virusMultivitamin supplementsChild morbidityChild healthVitamin supplementsLower riskRespiratory rateType 1
2001
Determinants of low birth weight among HIV-infected pregnant women in Tanzania 1 , 2 , 3
Dreyfuss M, Msamanga G, Spiegelman D, Hunter D, Urassa E, Hertzmark E, Fawzi W. Determinants of low birth weight among HIV-infected pregnant women in Tanzania 1 , 2 , 3. American Journal Of Clinical Nutrition 2001, 74: 814-826. PMID: 11722965, DOI: 10.1093/ajcn/74.6.814.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBirth WeightCohort StudiesDisease ProgressionFemaleHIV InfectionsHumansIncidenceInfant, Low Birth WeightInfant, NewbornInfant, Small for Gestational AgeInfectious Disease Transmission, VerticalLymphocyte CountMalariaMaternal WelfareMiddle AgedOdds RatioParasitic DiseasesPregnancyPregnancy Complications, InfectiousPregnancy OutcomeRandomized Controlled Trials as TopicRisk FactorsTanzaniaConceptsLow birth weightInfant HIV infectionBirth weightHIV infectionMaternal weightRisk factorsIncidence of LBWLow serum vitamin E concentrationsPredictors of LBWCell countAdvanced stage HIV diseaseLower CD8 cell countsMultivariate-adjusted linear regression modelsSerum vitamin E concentrationsInfant risk factorsCD4 cell countCD8 cell countsGestational age statusHIV disease progressionIntestinal parasitic infectionsMean birth weightPlasmodium falciparum malariaHIV-positive womenMidupper arm circumferencePrenatal care clinicsDifferences in perinatal transmission among human immunodeficiency virus type 1 genotypes.
Renjifo B, Fawzi W, Mwakagile D, Hunter D, Msamanga G, Spiegelman D, Garland M, Kagoma C, Kim A, Chaplin B, Hertzmark E, Essex M. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. Human Virology 2001, 4: 16-25. PMID: 11213929.Peer-Reviewed Original ResearchMeSH KeywordsBase SequenceCapsidCapsid ProteinsCase-Control StudiesDNA, ViralDouble-Blind MethodFemaleGag Gene Products, Human Immunodeficiency VirusGene Products, envGene Products, gagGenotypeHIV Core Protein p24HIV InfectionsHIV-1HumansInfantInfant, NewbornMolecular Sequence DataRisk FactorsViral ProteinsConceptsHIV-1 genetic subtypesCD4 cell countHIV-1 genotypesCell countGenetic subtypesHIV-1 subtype AHIV-1 subtype CHuman immunodeficiency virus type 1Vertical transmissionHuman immunodeficiency virus type 1 genotypesImmunodeficiency virus type 1Intersubtype recombinant virusesMaternal risk factorsLogistic regression analysisType 1 genotypeVirus type 1HIV-1 GagPerinatal transmissionSubtype CRisk factorsSubtype AHIV-1Intersubtype recombinantsType 1Differential risk
1999
Risk factors for cervical squamous intraepithelial lesions among HIV‐1 seropositive women in Dar es Salaam, Tanzania
Kapiga SH, Msamanga GI, Spiegelman D, Mwakyoma H, Fawzi WW, Hunter DJ. Risk factors for cervical squamous intraepithelial lesions among HIV‐1 seropositive women in Dar es Salaam, Tanzania. International Journal Of Gynecology & Obstetrics 1999, 67: 87-94. PMID: 10636052, DOI: 10.1016/s0020-7292(99)00125-3.Peer-Reviewed Original ResearchConceptsSquamous intraepithelial lesionsCervical squamous intraepithelial lesionsRisk factorsIntraepithelial lesionsPrevalence of SILRisk of SILHigh-grade squamous intraepithelial lesionsLow-grade squamous intraepithelial lesionsHIV-1-seropositive womenMid-upper arm circumferenceNon-significant increased riskFederation of GynecologyDar es SalaamLifetime sexual partnersLymphocyte subsetsSeropositive womenIncreased riskArm circumferenceCervical smearsLive birthsCell countSexual partnersHIVWomenSexual behaviorElevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy
Shevitz A, Knox T, Spiegelman D, Roubenoff R, Gorbach S, Skolnik P. Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy. AIDS 1999, 13: 1351-1357. PMID: 10449288, DOI: 10.1097/00002030-199907300-00012.Peer-Reviewed Original ResearchConceptsFat-free massActive antiretroviral therapyHAART useHIV RNAAntiretroviral therapyCohort studyViral burdenKJ/dayHIV-seropositive menCD4 cell countHIV-seropositive personsLog10 copies/Energy expenditureLarge cohort studyIndependent effectsCross-sectional analysisHIV diseaseMedication regimensViral loadCopies/Adjusted REECell countElevated REEViral replicationHAART